APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pregabalin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pregabalin Market Outlook and Growth Opportunities 2026

19 December 2025213 pages

Choose your research edition.

Industry ResearchPregabalin Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pregabalin Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pregabalin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pregabalin Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Pregabalin Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Pregabalin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pregabalin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pregabalin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pregabalin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pregabalin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pregabalin market include Zhejiang Huahai Pharmaceutical, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, Changzhou Pharmaceutical Factory (CPF), ZCL Chemicals, Vasudha Pharma Chem, Srini Pharmaceuticals, Olon S.p.A. and Maps Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pregabalin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pregabalin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pregabalin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pregabalin market size, projected growth trends, production technologies, key applications, and end-use industries.

Pregabalin Segment by Company

Zhejiang Huahai Pharmaceutical

Teva Pharmaceutical Industries

Sun Pharmaceutical Industries

Changzhou Pharmaceutical Factory (CPF)

ZCL Chemicals

Vasudha Pharma Chem

Srini Pharmaceuticals

Olon S.p.A.

Maps Laboratories

Laurus Labs

Hikal

Glenmark Life Sciences

Dongbang FTL

Divi’s Laboratories

Divi’s Laboratories

CTX Life Sciences

Chemo Iberica

Bazayan

BAL Pharma

Aurobindo Pharma

ARITE Pharmaceutical

Angels Pharma

Almelo Pvt. Ltd.

AASraw Biochemical Technology

Pregabalin Segment by Type

Capsule

Oral Solution

Tablet

Pregabalin Segment by Application

Hospitals

Clinics

Others

Pregabalin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pregabalin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pregabalin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pregabalin significant trends, drivers, influence factors in global and regions.

6. To analyze Pregabalin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregabalin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pregabalin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregabalin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pregabalin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pregabalin industry.

Chapter 3: Detailed analysis of Pregabalin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pregabalin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pregabalin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pregabalin Industry Trends Table 2. Pregabalin Industry Drivers Table 3. Pregabalin Industry Opportunities and Challenges Table 4. Pregabalin Industry Restraints Table 5. Global Pregabalin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pregabalin Revenue Share by Company (2021-2026) Table 7. Global Pregabalin Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Pregabalin Sales Volume Share by Company (2021-2026) Table 9. Global Pregabalin Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Pregabalin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pregabalin Key Company Manufacturing Base & Headquarters Table 12. Global Pregabalin Company, Product Type & Application Table 13. Global Pregabalin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pregabalin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Capsule Table 18. Significant Companies of Oral Solution Table 19. Significant Companies of Tablet Table 20. Global Pregabalin Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Pregabalin Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Pregabalin Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Pregabalin Sales Volume Share by Type (2021-2026) Table 24. Global Pregabalin Sales Volume Share by Type (2027-2032) Table 25. Global Pregabalin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pregabalin Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Pregabalin Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Pregabalin Sales Value Share by Type (2021-2026) Table 29. Global Pregabalin Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Significant Companies of Others Table 33. Global Pregabalin Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Pregabalin Sales Volume by Application (2021-2026) & (W Units) Table 35. Global Pregabalin Sales Volume by Application (2027-2032) & (W Units) Table 36. Global Pregabalin Sales Volume Share by Application (2021-2026) Table 37. Global Pregabalin Sales Volume Share by Application (2027-2032) Table 38. Global Pregabalin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pregabalin Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pregabalin Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pregabalin Sales Value Share by Application (2021-2026) Table 42. Global Pregabalin Sales Value Share by Application (2027-2032) Table 43. Global Pregabalin Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Pregabalin Sales by Region (2021-2026) & (W Units) Table 45. Global Pregabalin Sales Market Share by Region (2021-2026) Table 46. Global Pregabalin Sales by Region (2027-2032) & (W Units) Table 47. Global Pregabalin Sales Market Share by Region (2027-2032) Table 48. Global Pregabalin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pregabalin Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pregabalin Sales Value Share by Region (2021-2026) Table 51. Global Pregabalin Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pregabalin Sales Value Share by Region (2027-2032) Table 53. Global Pregabalin Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Pregabalin Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Pregabalin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Global Pregabalin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pregabalin Sales by Country (2021-2026) & (W Units) Table 58. Global Pregabalin Sales Market Share by Country (2021-2026) Table 59. Global Pregabalin Sales by Country (2027-2032) & (W Units) Table 60. Global Pregabalin Sales Market Share by Country (2027-2032) Table 61. Global Pregabalin Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pregabalin Sales Value Market Share by Country (2021-2026) Table 63. Global Pregabalin Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pregabalin Sales Value Market Share by Country (2027-2032) Table 65. Zhejiang Huahai Pharmaceutical Company Information Table 66. Zhejiang Huahai Pharmaceutical Business Overview Table 67. Zhejiang Huahai Pharmaceutical Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolio Table 69. Zhejiang Huahai Pharmaceutical Recent Development Table 70. Teva Pharmaceutical Industries Company Information Table 71. Teva Pharmaceutical Industries Business Overview Table 72. Teva Pharmaceutical Industries Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Teva Pharmaceutical Industries Pregabalin Product Portfolio Table 74. Teva Pharmaceutical Industries Recent Development Table 75. Sun Pharmaceutical Industries Company Information Table 76. Sun Pharmaceutical Industries Business Overview Table 77. Sun Pharmaceutical Industries Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sun Pharmaceutical Industries Pregabalin Product Portfolio Table 79. Sun Pharmaceutical Industries Recent Development Table 80. Changzhou Pharmaceutical Factory (CPF) Company Information Table 81. Changzhou Pharmaceutical Factory (CPF) Business Overview Table 82. Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolio Table 84. Changzhou Pharmaceutical Factory (CPF) Recent Development Table 85. ZCL Chemicals Company Information Table 86. ZCL Chemicals Business Overview Table 87. ZCL Chemicals Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. ZCL Chemicals Pregabalin Product Portfolio Table 89. ZCL Chemicals Recent Development Table 90. Vasudha Pharma Chem Company Information Table 91. Vasudha Pharma Chem Business Overview Table 92. Vasudha Pharma Chem Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Vasudha Pharma Chem Pregabalin Product Portfolio Table 94. Vasudha Pharma Chem Recent Development Table 95. Srini Pharmaceuticals Company Information Table 96. Srini Pharmaceuticals Business Overview Table 97. Srini Pharmaceuticals Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Srini Pharmaceuticals Pregabalin Product Portfolio Table 99. Srini Pharmaceuticals Recent Development Table 100. Olon S.p.A. Company Information Table 101. Olon S.p.A. Business Overview Table 102. Olon S.p.A. Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Olon S.p.A. Pregabalin Product Portfolio Table 104. Olon S.p.A. Recent Development Table 105. Maps Laboratories Company Information Table 106. Maps Laboratories Business Overview Table 107. Maps Laboratories Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Maps Laboratories Pregabalin Product Portfolio Table 109. Maps Laboratories Recent Development Table 110. Laurus Labs Company Information Table 111. Laurus Labs Business Overview Table 112. Laurus Labs Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Laurus Labs Pregabalin Product Portfolio Table 114. Laurus Labs Recent Development Table 115. Hikal Company Information Table 116. Hikal Business Overview Table 117. Hikal Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Hikal Pregabalin Product Portfolio Table 119. Hikal Recent Development Table 120. Glenmark Life Sciences Company Information Table 121. Glenmark Life Sciences Business Overview Table 122. Glenmark Life Sciences Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Glenmark Life Sciences Pregabalin Product Portfolio Table 124. Glenmark Life Sciences Recent Development Table 125. Dongbang FTL Company Information Table 126. Dongbang FTL Business Overview Table 127. Dongbang FTL Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Dongbang FTL Pregabalin Product Portfolio Table 129. Dongbang FTL Recent Development Table 130. Divi’s Laboratories Company Information Table 131. Divi’s Laboratories Business Overview Table 132. Divi’s Laboratories Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Divi’s Laboratories Pregabalin Product Portfolio Table 134. Divi’s Laboratories Recent Development Table 135. Divi’s Laboratories Company Information Table 136. Divi’s Laboratories Business Overview Table 137. Divi’s Laboratories Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Divi’s Laboratories Pregabalin Product Portfolio Table 139. Divi’s Laboratories Recent Development Table 140. CTX Life Sciences Company Information Table 141. CTX Life Sciences Business Overview Table 142. CTX Life Sciences Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. CTX Life Sciences Pregabalin Product Portfolio Table 144. CTX Life Sciences Recent Development Table 145. Chemo Iberica Company Information Table 146. Chemo Iberica Business Overview Table 147. Chemo Iberica Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Chemo Iberica Pregabalin Product Portfolio Table 149. Chemo Iberica Recent Development Table 150. Bazayan Company Information Table 151. Bazayan Business Overview Table 152. Bazayan Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Bazayan Pregabalin Product Portfolio Table 154. Bazayan Recent Development Table 155. BAL Pharma Company Information Table 156. BAL Pharma Business Overview Table 157. BAL Pharma Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. BAL Pharma Pregabalin Product Portfolio Table 159. BAL Pharma Recent Development Table 160. Aurobindo Pharma Company Information Table 161. Aurobindo Pharma Business Overview Table 162. Aurobindo Pharma Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Aurobindo Pharma Pregabalin Product Portfolio Table 164. Aurobindo Pharma Recent Development Table 165. ARITE Pharmaceutical Company Information Table 166. ARITE Pharmaceutical Business Overview Table 167. ARITE Pharmaceutical Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. ARITE Pharmaceutical Pregabalin Product Portfolio Table 169. ARITE Pharmaceutical Recent Development Table 170. Angels Pharma Company Information Table 171. Angels Pharma Business Overview Table 172. Angels Pharma Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. Angels Pharma Pregabalin Product Portfolio Table 174. Angels Pharma Recent Development Table 175. Almelo Pvt. Ltd. Company Information Table 176. Almelo Pvt. Ltd. Business Overview Table 177. Almelo Pvt. Ltd. Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 178. Almelo Pvt. Ltd. Pregabalin Product Portfolio Table 179. Almelo Pvt. Ltd. Recent Development Table 180. AASraw Biochemical Technology Company Information Table 181. AASraw Biochemical Technology Business Overview Table 182. AASraw Biochemical Technology Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 183. AASraw Biochemical Technology Pregabalin Product Portfolio Table 184. AASraw Biochemical Technology Recent Development Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. Pregabalin Distributors List Table 188. Pregabalin Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. Pregabalin Product Image Figure 2. Global Pregabalin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pregabalin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pregabalin Sales (2021-2032) & (W Units) Figure 5. Global Pregabalin Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Pregabalin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Capsule Image Figure 10. Oral Solution Image Figure 11. Tablet Image Figure 12. Global Pregabalin Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Pregabalin Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Pregabalin Sales Volume Share by Type (2021-2032) Figure 15. Global Pregabalin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pregabalin Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pregabalin Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Others Image Figure 21. Global Pregabalin Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Pregabalin Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pregabalin Sales Volume Share by Application (2021-2032) Figure 24. Global Pregabalin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pregabalin Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pregabalin Sales Value Share by Application (2021-2032) Figure 27. Global Pregabalin Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 28. Global Pregabalin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pregabalin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pregabalin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pregabalin Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pregabalin Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pregabalin Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pregabalin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pregabalin Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pregabalin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pregabalin Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pregabalin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pregabalin Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pregabalin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pregabalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pregabalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pregabalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pregabalin Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pregabalin Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Oral Solution
  • Tablet
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Changzhou Pharmaceutical Factory (CPF)
  • ZCL Chemicals
  • Vasudha Pharma Chem
  • Srini Pharmaceuticals
  • Olon S.p.A.
  • Maps Laboratories
  • Laurus Labs
  • Hikal
  • Glenmark Life Sciences
  • Dongbang FTL
  • Divi’s Laboratories
  • Divi’s Laboratories
  • CTX Life Sciences
  • Chemo Iberica
  • Bazayan
  • BAL Pharma
  • Aurobindo Pharma
  • ARITE Pharmaceutical
  • Angels Pharma
  • Almelo Pvt. Ltd.
  • AASraw Biochemical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pregabalin Sales Value (2021-2032)
  4. 1.2.2 Global Pregabalin Sales Volume (2021-2032)
  5. 1.2.3 Global Pregabalin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pregabalin Market Dynamics
  1. 2.1 Pregabalin Industry Trends
  2. 2.2 Pregabalin Industry Drivers
  3. 2.3 Pregabalin Industry Opportunities and Challenges
  4. 2.4 Pregabalin Industry Restraints
3 Pregabalin Market by Company
  1. 3.1 Global Pregabalin Company Revenue Ranking in 2025
  2. 3.2 Global Pregabalin Revenue by Company (2021-2026)
  3. 3.3 Global Pregabalin Sales Volume by Company (2021-2026)
  4. 3.4 Global Pregabalin Average Price by Company (2021-2026)
  5. 3.5 Global Pregabalin Company Ranking (2024-2026)
  6. 3.6 Global Pregabalin Company Manufacturing Base and Headquarters
  7. 3.7 Global Pregabalin Company Product Type and Application
  8. 3.8 Global Pregabalin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pregabalin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pregabalin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pregabalin Market by Type
  1. 4.1 Pregabalin Type Introduction
  2. 4.1.1 Capsule
  3. 4.1.2 Oral Solution
  4. 4.1.3 Tablet
  5. 4.2 Global Pregabalin Sales Volume by Type
  6. 4.2.1 Global Pregabalin Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pregabalin Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Pregabalin Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Pregabalin Sales Value by Type
  10. 4.3.1 Global Pregabalin Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pregabalin Sales Value by Type (2021-2032)
  12. 4.3.3 Global Pregabalin Sales Value Share by Type (2021-2032)
5 Pregabalin Market by Application
  1. 5.1 Pregabalin Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Pregabalin Sales Volume by Application
  6. 5.2.1 Global Pregabalin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pregabalin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pregabalin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pregabalin Sales Value by Application
  10. 5.3.1 Global Pregabalin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pregabalin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pregabalin Sales Value Share by Application (2021-2032)
6 Pregabalin Regional Sales and Value Analysis
  1. 6.1 Global Pregabalin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pregabalin Sales by Region (2021-2032)
  3. 6.2.1 Global Pregabalin Sales by Region: 2021-2026
  4. 6.2.2 Global Pregabalin Sales by Region (2027-2032)
  5. 6.3 Global Pregabalin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pregabalin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pregabalin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pregabalin Sales Value by Region (2027-2032)
  9. 6.5 Global Pregabalin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pregabalin Sales Value (2021-2032)
  12. 6.6.2 North America Pregabalin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pregabalin Sales Value (2021-2032)
  15. 6.7.2 Europe Pregabalin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pregabalin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pregabalin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pregabalin Sales Value (2021-2032)
  21. 6.9.2 South America Pregabalin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pregabalin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pregabalin Sales Value Share by Country, 2025 VS 2032
7 Pregabalin Country-level Sales and Value Analysis
  1. 7.1 Global Pregabalin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pregabalin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pregabalin Sales by Country (2021-2032)
  4. 7.3.1 Global Pregabalin Sales by Country (2021-2026)
  5. 7.3.2 Global Pregabalin Sales by Country (2027-2032)
  6. 7.4 Global Pregabalin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pregabalin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pregabalin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pregabalin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pregabalin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pregabalin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pregabalin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pregabalin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pregabalin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pregabalin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pregabalin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pregabalin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pregabalin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pregabalin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pregabalin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pregabalin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pregabalin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pregabalin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pregabalin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pregabalin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pregabalin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pregabalin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pregabalin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pregabalin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pregabalin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pregabalin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pregabalin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pregabalin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pregabalin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pregabalin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pregabalin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pregabalin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pregabalin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pregabalin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pregabalin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pregabalin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pregabalin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pregabalin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pregabalin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pregabalin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pregabalin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pregabalin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pregabalin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pregabalin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pregabalin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pregabalin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pregabalin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pregabalin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pregabalin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pregabalin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pregabalin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pregabalin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pregabalin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pregabalin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pregabalin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pregabalin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pregabalin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pregabalin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pregabalin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pregabalin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pregabalin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pregabalin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pregabalin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pregabalin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pregabalin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pregabalin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pregabalin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pregabalin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pregabalin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pregabalin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pregabalin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pregabalin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pregabalin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pregabalin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pregabalin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pregabalin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pregabalin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pregabalin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pregabalin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pregabalin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pregabalin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pregabalin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pregabalin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pregabalin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pregabalin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pregabalin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pregabalin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Huahai Pharmaceutical
  2. 8.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Huahai Pharmaceutical Pregabalin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolio
  6. 8.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 8.2 Teva Pharmaceutical Industries
  8. 8.2.1 Teva Pharmaceutical Industries Company Information
  9. 8.2.2 Teva Pharmaceutical Industries Business Overview
  10. 8.2.3 Teva Pharmaceutical Industries Pregabalin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceutical Industries Pregabalin Product Portfolio
  12. 8.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 8.3 Sun Pharmaceutical Industries
  14. 8.3.1 Sun Pharmaceutical Industries Company Information
  15. 8.3.2 Sun Pharmaceutical Industries Business Overview
  16. 8.3.3 Sun Pharmaceutical Industries Pregabalin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Industries Pregabalin Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Industries Recent Developments
  19. 8.4 Changzhou Pharmaceutical Factory (CPF)
  20. 8.4.1 Changzhou Pharmaceutical Factory (CPF) Company Information
  21. 8.4.2 Changzhou Pharmaceutical Factory (CPF) Business Overview
  22. 8.4.3 Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolio
  24. 8.4.5 Changzhou Pharmaceutical Factory (CPF) Recent Developments
  25. 8.5 ZCL Chemicals
  26. 8.5.1 ZCL Chemicals Company Information
  27. 8.5.2 ZCL Chemicals Business Overview
  28. 8.5.3 ZCL Chemicals Pregabalin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ZCL Chemicals Pregabalin Product Portfolio
  30. 8.5.5 ZCL Chemicals Recent Developments
  31. 8.6 Vasudha Pharma Chem
  32. 8.6.1 Vasudha Pharma Chem Company Information
  33. 8.6.2 Vasudha Pharma Chem Business Overview
  34. 8.6.3 Vasudha Pharma Chem Pregabalin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Vasudha Pharma Chem Pregabalin Product Portfolio
  36. 8.6.5 Vasudha Pharma Chem Recent Developments
  37. 8.7 Srini Pharmaceuticals
  38. 8.7.1 Srini Pharmaceuticals Company Information
  39. 8.7.2 Srini Pharmaceuticals Business Overview
  40. 8.7.3 Srini Pharmaceuticals Pregabalin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Srini Pharmaceuticals Pregabalin Product Portfolio
  42. 8.7.5 Srini Pharmaceuticals Recent Developments
  43. 8.8 Olon S.p.A.
  44. 8.8.1 Olon S.p.A. Company Information
  45. 8.8.2 Olon S.p.A. Business Overview
  46. 8.8.3 Olon S.p.A. Pregabalin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Olon S.p.A. Pregabalin Product Portfolio
  48. 8.8.5 Olon S.p.A. Recent Developments
  49. 8.9 Maps Laboratories
  50. 8.9.1 Maps Laboratories Company Information
  51. 8.9.2 Maps Laboratories Business Overview
  52. 8.9.3 Maps Laboratories Pregabalin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Maps Laboratories Pregabalin Product Portfolio
  54. 8.9.5 Maps Laboratories Recent Developments
  55. 8.10 Laurus Labs
  56. 8.10.1 Laurus Labs Company Information
  57. 8.10.2 Laurus Labs Business Overview
  58. 8.10.3 Laurus Labs Pregabalin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Laurus Labs Pregabalin Product Portfolio
  60. 8.10.5 Laurus Labs Recent Developments
  61. 8.11 Hikal
  62. 8.11.1 Hikal Company Information
  63. 8.11.2 Hikal Business Overview
  64. 8.11.3 Hikal Pregabalin Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hikal Pregabalin Product Portfolio
  66. 8.11.5 Hikal Recent Developments
  67. 8.12 Glenmark Life Sciences
  68. 8.12.1 Glenmark Life Sciences Company Information
  69. 8.12.2 Glenmark Life Sciences Business Overview
  70. 8.12.3 Glenmark Life Sciences Pregabalin Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Glenmark Life Sciences Pregabalin Product Portfolio
  72. 8.12.5 Glenmark Life Sciences Recent Developments
  73. 8.13 Dongbang FTL
  74. 8.13.1 Dongbang FTL Company Information
  75. 8.13.2 Dongbang FTL Business Overview
  76. 8.13.3 Dongbang FTL Pregabalin Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Dongbang FTL Pregabalin Product Portfolio
  78. 8.13.5 Dongbang FTL Recent Developments
  79. 8.14 Divi’s Laboratories
  80. 8.14.1 Divi’s Laboratories Company Information
  81. 8.14.2 Divi’s Laboratories Business Overview
  82. 8.14.3 Divi’s Laboratories Pregabalin Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Divi’s Laboratories Pregabalin Product Portfolio
  84. 8.14.5 Divi’s Laboratories Recent Developments
  85. 8.15 Divi’s Laboratories
  86. 8.15.1 Divi’s Laboratories Company Information
  87. 8.15.2 Divi’s Laboratories Business Overview
  88. 8.15.3 Divi’s Laboratories Pregabalin Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Divi’s Laboratories Pregabalin Product Portfolio
  90. 8.15.5 Divi’s Laboratories Recent Developments
  91. 8.16 CTX Life Sciences
  92. 8.16.1 CTX Life Sciences Company Information
  93. 8.16.2 CTX Life Sciences Business Overview
  94. 8.16.3 CTX Life Sciences Pregabalin Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 CTX Life Sciences Pregabalin Product Portfolio
  96. 8.16.5 CTX Life Sciences Recent Developments
  97. 8.17 Chemo Iberica
  98. 8.17.1 Chemo Iberica Company Information
  99. 8.17.2 Chemo Iberica Business Overview
  100. 8.17.3 Chemo Iberica Pregabalin Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Chemo Iberica Pregabalin Product Portfolio
  102. 8.17.5 Chemo Iberica Recent Developments
  103. 8.18 Bazayan
  104. 8.18.1 Bazayan Company Information
  105. 8.18.2 Bazayan Business Overview
  106. 8.18.3 Bazayan Pregabalin Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Bazayan Pregabalin Product Portfolio
  108. 8.18.5 Bazayan Recent Developments
  109. 8.19 BAL Pharma
  110. 8.19.1 BAL Pharma Company Information
  111. 8.19.2 BAL Pharma Business Overview
  112. 8.19.3 BAL Pharma Pregabalin Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 BAL Pharma Pregabalin Product Portfolio
  114. 8.19.5 BAL Pharma Recent Developments
  115. 8.20 Aurobindo Pharma
  116. 8.20.1 Aurobindo Pharma Company Information
  117. 8.20.2 Aurobindo Pharma Business Overview
  118. 8.20.3 Aurobindo Pharma Pregabalin Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Aurobindo Pharma Pregabalin Product Portfolio
  120. 8.20.5 Aurobindo Pharma Recent Developments
  121. 8.21 ARITE Pharmaceutical
  122. 8.21.1 ARITE Pharmaceutical Company Information
  123. 8.21.2 ARITE Pharmaceutical Business Overview
  124. 8.21.3 ARITE Pharmaceutical Pregabalin Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 ARITE Pharmaceutical Pregabalin Product Portfolio
  126. 8.21.5 ARITE Pharmaceutical Recent Developments
  127. 8.22 Angels Pharma
  128. 8.22.1 Angels Pharma Company Information
  129. 8.22.2 Angels Pharma Business Overview
  130. 8.22.3 Angels Pharma Pregabalin Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Angels Pharma Pregabalin Product Portfolio
  132. 8.22.5 Angels Pharma Recent Developments
  133. 8.23 Almelo Pvt. Ltd.
  134. 8.23.1 Almelo Pvt. Ltd. Company Information
  135. 8.23.2 Almelo Pvt. Ltd. Business Overview
  136. 8.23.3 Almelo Pvt. Ltd. Pregabalin Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Almelo Pvt. Ltd. Pregabalin Product Portfolio
  138. 8.23.5 Almelo Pvt. Ltd. Recent Developments
  139. 8.24 AASraw Biochemical Technology
  140. 8.24.1 AASraw Biochemical Technology Company Information
  141. 8.24.2 AASraw Biochemical Technology Business Overview
  142. 8.24.3 AASraw Biochemical Technology Pregabalin Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 AASraw Biochemical Technology Pregabalin Product Portfolio
  144. 8.24.5 AASraw Biochemical Technology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pregabalin Value Chain Analysis
  2. 9.1.1 Pregabalin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pregabalin Sales Mode & Process
  6. 9.2 Pregabalin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pregabalin Distributors
  9. 9.2.3 Pregabalin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst